Your browser doesn't support javascript.
loading
Adjuvant treatment for elderly patients with early-stage lung cancer treated with limited resection.
Veluswamy, Rajwanth R; Mhango, Grace; Bonomi, Marcelo; Neugut, Alfred I; Hershman, Dawn L; Aldridge, Melissa D; Wisnivesky, Juan P.
Afiliação
  • Veluswamy RR; 1 Division of General Internal Medicine.
Ann Am Thorac Soc ; 10(6): 622-8, 2013 Dec.
Article em En | MEDLINE | ID: mdl-24024700
ABSTRACT

OBJECTIVES:

Limited resection is commonly used for treating older patients with early-stage non-small cell lung cancer (NSCLC) who cannot tolerate lobectomy. However, parenchymal-sparing procedures leave patients at increased risk of recurrence. The role of postoperative radiotherapy (PORT) and chemotherapy after limited resection is not established.

METHODS:

We identified 1,929 patients with stage I-II (≤ 5 cm in size) NSCLC who underwent limited resection (wedge or segmentectomy) from the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database. Using propensity score methods, we compared toxicity and survival of patients treated with limited resection alone, PORT, adjuvant chemotherapy, or PORT and chemotherapy. We conducted secondary analysis stratifying the sample by size (>2-5 cm), stage (IA vs. IB/IIA), and type of limited resection (wedge resection vs. segmentectomy). MEASUREMENTS AND MAIN

RESULTS:

Overall, 1,656 (85.8%), 159 (8.3%), 74 (3.8%), and 40 (2.1%) patients were treated with limited resection alone, PORT, adjuvant chemotherapy, or PORT and chemotherapy, respectively. Adjusted analysis using inverse probability weighting showed that PORT (hazard ratio [HR], 1.57; 95% confidence interval [CI], 1.45-1.69), adjuvant chemotherapy (HR, 1.48; 95% CI, 1.36-1.61), and PORT and chemotherapy (HR, 1.73; 95% CI, 1.61-1.86) were associated with worse survival compared with limited resection alone. Similar results were obtained in secondary analyses. Compared with limited resection alone, the adjusted odds ratios for toxicity were 1.97 (95% CI, 1.6-2.4), 3.15 (95% CI, 2.58-3.85), 2.59 (95% CI, 2.0-3.4) for PORT, chemotherapy, and PORT and chemotherapy, respectively.

CONCLUSIONS:

PORT and adjuvant chemotherapy are not beneficial and appear to be associated with increased toxicity and worse survival after limited resection in elderly patients with early-stage NSCLC. Alternative strategies should be explored to improve local control.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Quimioterapia Adjuvante / Carcinoma Pulmonar de Células não Pequenas / Radioterapia Adjuvante / Quimiorradioterapia Adjuvante / Neoplasias Pulmonares Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 País/Região como assunto: America do norte Idioma: En Revista: Ann Am Thorac Soc Ano de publicação: 2013 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Quimioterapia Adjuvante / Carcinoma Pulmonar de Células não Pequenas / Radioterapia Adjuvante / Quimiorradioterapia Adjuvante / Neoplasias Pulmonares Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 País/Região como assunto: America do norte Idioma: En Revista: Ann Am Thorac Soc Ano de publicação: 2013 Tipo de documento: Article